Yes that part of the blog & strategy was right but how hard/easy is it to delist? We may get the same result in a way - the company would have needed the money so everyone was on the hook - sure we save a mill a year but lose liquidity and governance (that was the flaw in his argument - if it did go dark the all the smaller holders lose genuine control/governance - despite his comments about the bloc from what I have heard there is plenty of independence at Board level and the major shareholder definately doesnt get their way).
If the SP rallies to 15-20c then your scenario of 50m for 15% comes true. Not sure what they would do with $50m but I suspect we would raise $25m if it reached that level - ironically if it got to 15-20c we probably wouldn't need the money - it would probably be off the back of such a big partnership deal the upfront would cover us for years.
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
PYC
pyc therapeutics limited
Add to My Watchlist
0.40%
!
$1.27

Yes that part of the blog & strategy was right but how hard/easy...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 1380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | 1.265 |
2 | 16380 | 1.260 |
3 | 14380 | 1.255 |
3 | 103380 | 1.250 |
1 | 4000 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 1380 | 1 |
1.290 | 27010 | 3 |
1.295 | 25880 | 2 |
1.300 | 59168 | 4 |
1.325 | 9001 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online